The present study further examines for any difference in LC3B expression between oropharyngeal and oral cavity SCC patients through LC3B immunohistochemistry assessment and correlation with prognosis, clinical and pathological characteristics of patients. The gene discussed is MAP1LC3B; the disease is oral cavity squamous cell carcinoma.